Slate Money takes on EpiPen, passive investing, and hedge funds.

Slate Money on the EpiPen Outrage

Slate Money on the EpiPen Outrage

Slate’s weekly business and finance podcast.
Aug. 27 2016 2:02 AM

The Worse Than Marxism Edition

Slate Money on why we should be outraged at the makers of EpiPen, passive investing, and hedge funds.

1400x1400_podcast_slateMoney_slateplus

Listen to Episode No. 120 of Slate Money:

Advertisement

On this episode of Slate Money are hosts Felix Salmon of Fusion, Slate Moneybox columnist Jordan Weissmann, and Linette Lopez, senior finance correspondent at Business Insider (@lopezlinette).

Topics discussed on today’s show include:                            

Check out other Panoply podcasts at itunes.com/panoply.

Production by Veralyn Williams.

Linette Lopez is the finance editor at Business Insider. Follow her on Twitter.

Felix Salmon is a senior editor at Fusion.

Jordan Weissmann is Slate’s senior business and economics correspondent.